Lista de obras -

A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes

artículo científico publicado en 2004

Application of High-Sensitivity Troponin in Suspected Myocardial Infarction

scientific article published on 1 June 2019

Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney function

artículo científico publicado en 2024

Biochemical indicators of cardiac and renal function in a healthy elderly population

artículo científico publicado en 2004

Diagnosis of acute myocardial infarction in the presence of left bundle branch block

artículo científico publicado en 2019

Discontinuation of smokeless tobacco and mortality risk after myocardial infarction

artículo científico publicado en 2014

Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip

artículo científico publicado en 2015

Evaluation of Temporal Changes in Cardiovascular Biomarker Concentrations Improves Risk Prediction in an Elderly Population from the Community

artículo científico publicado en 2016

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology

artículo científico publicado en 2004

Fourth universal definition of myocardial infarction (2018)

article by Kristian Thygesen et al published 25 August 2018 in European Heart Journal

GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men

artículo científico publicado en 2013

Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome

scientific article published on 11 December 2009

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

artículo científico publicado en 2009

High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men.

artículo científico publicado en 2013

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.

artículo científico publicado en 2017

Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and design

artículo científico publicado en 2010

Influence on coagulation activity by subcutaneous LMW heparin as an adjuvant treatment to fibrinolysis in acute myocardial infarction

artículo científico publicado en 2002

Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction—the ASSENT Plus study ⬇️

artículo científico publicado el 1 de mayo de 2003

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arte

artículo científico publicado en 2003

N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease

artículo científico publicado en 2003

Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial

artículo científico publicado en 2004

Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome

artículo científico publicado en 2008

Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction

scientific article published on 19 April 2006

Prehospital diagnosis and start of treatment reduces time delay and mortality in real-life patients with STEMI.

artículo científico publicado en 2005

Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects

artículo científico publicado en 2008

Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice

artículo científico publicado en 2004

Prognostic Importance of Sex-Specific Cardiac Troponin T 99(th) Percentiles in Suspected Acute Coronary Syndrome.

artículo científico publicado en 2016

Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome

artículo científico publicado en 2007

Relation between cardiovascular disease risk markers and brain infarcts detected by magnetic resonance imaging in an elderly population

artículo científico publicado en 2014

Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014

scientific article published on 01 November 2018

Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time

artículo científico publicado en 2017

Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy

artículo científico publicado en 2005

Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome

artículo científico publicado en 2006

The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients

artículo científico publicado en 2017

Third Universal Definition of Myocardial Infarction

artículo científico publicado en 2012

Treatment and Prognosis of Myocardial Infarction Outside Cardiology Departments

artículo científico publicado en 2020

Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial

artículo científico publicado en 2003

Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction

artículo científico publicado en 2002

Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy

artículo científico publicado en 2003

Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy

artículo científico publicado en 2006

Two-hour diagnostic algorithms for early assessment of patients with acute chest pain--Implications of lowering the cardiac troponin I cut-off to the 97.5th percentile

artículo científico publicado en 2015

Unrecognized myocardial infarctions detected by cardiac magnetic resonance imaging are associated with cardiac troponin I levels

artículo científico publicado en 2016

Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis

artículo científico publicado en 2015

Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).

artículo científico publicado en 2005

[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]

artículo científico publicado en 2004

[Riks-HIA will develop a new index for areas with room for improvement]

artículo científico publicado en 2012

Lista de obras de

A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes

Application of High-Sensitivity Troponin in Suspected Myocardial Infarction

Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney function

Biochemical indicators of cardiac and renal function in a healthy elderly population

Diagnosis of acute myocardial infarction in the presence of left bundle branch block

Discontinuation of smokeless tobacco and mortality risk after myocardial infarction

Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip

Evaluation of Temporal Changes in Cardiovascular Biomarker Concentrations Improves Risk Prediction in an Elderly Population from the Community

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology

Fourth universal definition of myocardial infarction (2018)

GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men

Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men.

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.

Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and design

Influence on coagulation activity by subcutaneous LMW heparin as an adjuvant treatment to fibrinolysis in acute myocardial infarction

Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction—the ASSENT Plus study ⬇️

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arte

N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease

Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial

Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome

Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction

Prehospital diagnosis and start of treatment reduces time delay and mortality in real-life patients with STEMI.

Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects

Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice

Prognostic Importance of Sex-Specific Cardiac Troponin T 99(th) Percentiles in Suspected Acute Coronary Syndrome.

Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome

Relation between cardiovascular disease risk markers and brain infarcts detected by magnetic resonance imaging in an elderly population

Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014

Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time

Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy

Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome

The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients

Third Universal Definition of Myocardial Infarction

Treatment and Prognosis of Myocardial Infarction Outside Cardiology Departments

Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial

Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction

Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy

Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy

Two-hour diagnostic algorithms for early assessment of patients with acute chest pain--Implications of lowering the cardiac troponin I cut-off to the 97.5th percentile

Unrecognized myocardial infarctions detected by cardiac magnetic resonance imaging are associated with cardiac troponin I levels

Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis

Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).

[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]

[Riks-HIA will develop a new index for areas with room for improvement]